01 1Erregierre SpA
02 1Kalchem International inc
03 1Maithili Life Sciences Private Limited
01 1ISOXSUPRINE HCL
02 2Isoxsuprine Hydrochloride
01 1India
02 1Italy
03 1U.S.A
NDC Package Code : 49706-0921
Start Marketing Date : 2020-07-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 60592-242
Start Marketing Date : 2023-10-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 82053-001
Start Marketing Date : 2021-07-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Isoxsuprine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Isoxsuprine Hydrochloride, including repackagers and relabelers. The FDA regulates Isoxsuprine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Isoxsuprine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Isoxsuprine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Isoxsuprine Hydrochloride supplier is an individual or a company that provides Isoxsuprine Hydrochloride active pharmaceutical ingredient (API) or Isoxsuprine Hydrochloride finished formulations upon request. The Isoxsuprine Hydrochloride suppliers may include Isoxsuprine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Isoxsuprine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Isoxsuprine Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Isoxsuprine Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Isoxsuprine Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Isoxsuprine Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Isoxsuprine Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Isoxsuprine Hydrochloride suppliers with NDC on PharmaCompass.
We have 3 companies offering Isoxsuprine Hydrochloride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
